Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia
Dyantha I. van der Lee(Leiden University Medical Center), Marieke Griffioen(Leiden University Medical Center), Nadine E. Struckman(Leiden University Medical Center), J.H. Frederik Falkenburg(Leiden University Medical Center), Eva M. Argiro(Leiden University Medical Center), M. Willy Honders(Leiden University Medical Center), Sebastiaan N. J. Laan(Leiden University Medical Center), Rob C. M. de Jong(Leiden University Medical Center)
Cited by 3
Related Papers
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
|Bone Marrow Transplantation|2015|337
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
|Journal of Clinical Investigation|2019|232
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
|Bone Marrow Transplantation|2015|205
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
|Bone Marrow Transplantation|2014|178
Hematopoietic SCT in Europe: data and trends in 2011
|Bone Marrow Transplantation|2013|132